Visit CURE at http://curenet.org and BioBus Educational Programs at http://ctbiobus.org

September 2009

 



Affomix Corporation Seeks two full time Research Associates in Branford CT.  Required: Bachelor level degree in field of biology, including cellular and molecular, with 3 years of experience.  Resume and Cover to: jobs@affomix.com  Code: Aff707-09 (To view full job description: www.affomix.com)
Events Column
9/17  3:00 pm - 7:30 pm
2009 Cantor Colburn LLP / CCAT Innovation and Entrepreneurship Summit. Omni Hotel, New Haven more
9/22  MIT Enterprise Forum of CT Global Broadcast: MIT Professor Robert Langer on Breakthrough Medical Technologies more
10/6  5:15 pm - 7:30 pm
Licensing Executives Society NY Chapter Meeting: "Managing IP Innovation to Maximixe Profits" more
10/14  MIT Enterprise Forum of CT more
10/15  8:00 am - 2:00 pm
Harvard School of Public Health Symposium: "Neglected Infectious Diseases and Public Private Partnerships: What Works, What Doesn't, What's Next?" Downtown Harvard Club of Boston, Boston, MA more
10/21  3:30 pm - 6:00 pm
CURE/Yale BioHaven Entrepreneurship Series: Cara Therapeutics. Anlyan Center, Yale Medical School, New Haven. Watch for details.
11/11  MIT Enterprise Forum of CT more
11/18  3:30 pm - 6:00 pm
CURE/Yale BioHaven Entrepreneurship Series: Helix Therapeutics. Anlyan Center, Yale Medical School, New Haven. Watch for details.
2/10  MIT Enterprise Forum of CT more
3/10  MIT Enterprise Forum of CT more
4/7  MIT Enterprise Forum of CT more
5/5  MIT Enterprise Forum of CT more

CURE Speaks Out on Shielding Biologic Developers
From the desk of Paul Pescatello, President and CEO of CURE
 As part of its campaign to bring the economic significance of the bioscience industry to the attention of Connecticut lawmakers and the public, CURE has continued to speak out on industry issues. Recently I signed an op-ed in the Hartford Courant that called for protecting developers of the complex medicines known as biologics from copycat marketers. (View op-ed.) Earlier in the summer, I was interviewed by Harriet Jones of WNPR about the role of biotech in the state's economy. (View interview.)
For the full story
CURE Member News Digest
 454 Life Sciences collaborate with Eli Lilly and SeqWright
 Achillion comments on 2Q
 Alexion drug granted orphan status in Europe
 Amarin gets $3 million from private placement
 Applied Spine adds patients to trial
 Bayer HealthCare reports FDA approval of Kogenate®
 Boehringer Ingelheim announces Phase 3 lung cancer study
 Bristol-Myers Squibb says FDA has approved ONGLYZA™
 Connecicut Innovations invests in Soft Tissue Regeneration
 Danbury Hospital promotes Children's Health and Wellness
 Genomas marks fifth anniversary as genetic research anchor
 GlaxoSmithKline reports flu vaccine progress
 Hartford Hospital affiliates with The Hospital of Central CT
 Ethicon unit of Johnson & Johnson redesigns BIOPATCH®
 ManKind completes stock offering
 NanoViricides weighs anti herpes application
 Neurogen to be acquired by Ligand
 Pfizer in Phase 3 trial of Huntington drug
 PhRMA supports biosimilars legislation
  Protein Sciences gets $35 million contract from HHS
 Purdue Pharma to collaborate on sleep drug
 Rib-X reports positive Phase 2 results on radezolid
 UConn  newsletter reports OTC highlights
 Yale team identifies cell transport ions
For the full story
 
 
Copyright 2009 © Connecticut United for Research Excellence. All rights reserved.
Visit CURE at http://curenet.org and BioBus Educational Programs at http://ctbiobus.org
Click here for Archive of back issues.
Newsletter developed and edited by HarveyMalis Communications LLC, Guilford, Conn.

Managing Your Subscriptions
Click on the "Manage your subscription" link below and then on "Edit Your Profile." To subscribe to a publication, type a "y" in the box to the right of the publication name. To unsubscribe, leave the box blank.